Fundz

Ruthigen, Inc. reported raising $2.61 Million in an initial SEC Form D filing, from an offering of $2.61 Million

PUBLIC · PULMJun 16, 2015

Amount Raised

$2.61 Million

$2.61 Million sold, per SEC Form D (first sale Jun 16, 2015)

Round Type

Seed

FraminghamHealthcare

Who to call at Pulmatrix, and when

A new round usually means Pulmatrix is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Pulmatrix raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pulmatrix, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pulmatrix. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pulmatrix

Location

99 HAYDEN AVENUE

Framingham, Massachusetts, United States

About

Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE technology, which enables better delivery of drugs to the lungs. The company is dedicated to improving the lives of patients with respiratory diseases and advancing the field of inhaled therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pulmatrix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPeter L., Interim Chief Executive Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Pulmatrix's next move

See what Strategic adds

Pulmatrix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.